Green Cross Health Ltd · NZX:GXH
Green Cross Health — Shareholder Meeting (July 2019)
22 slides from Green Cross Health's shareholder meeting presentation, Jul 30, 2019
Slide 1: Annual Shareholders' Meeting
Annual Shareholders’ Meeting 30 July 2019 GXH Annual Shareholders’ Meeting Presentation 30 July 2019 Pg 1
Slide 2: Agenda
Agenda • Chairman’s address • Group Executive Officer’s address • Voting on Resolutions • General Q&A • Refreshments GXH Annual Shareholders’ Meeting Presentation 30 July 2019 Pg 2
Slide 3: Peter Merton, Chairman
Peter Merton Chairman GXH Annual Shareholders’ Meeting Presentation 30 July 2019 Pg 3
Slide 4: Rachael Newfield, Group CEO
Rachael Newfield Group CEO GXH Annual Shareholders’ Meeting Presentation 30 July 2019 Pg 4
Slide 5: Our Purpose
Our Purpose Working together to support healthier communities. We are passionately committed to the health and wellness of New Zealand, and to providing the best support, care and advice to our communities. This is our promise. GXH Annual Shareholders’ Meeting Presentation 30 July 2019 Pg 5
Slide 6: Financial Highlights
Financial Highlights Revenue Pharmacy $567.2m +5.6% Same Store Sales +1.1% EBITDA Medical $36.9m +2.3% Same Centre +4.9% Revenue Net Profit After Tax $16.1m +3.2%1 Consistent 3.5 cps Final Dividend (attributable to shareholders) Note: 1 2018 restated to incorporate changes in Accounting Standards an
Slide 7: Pharmacy Performance
Pharmacy Performance Pharmacy Operating Revenue Pharmacy Operating Profit $m $m 350 341.3 30 340.2 28.9 27.9 322.6 28 27.3 325 26 25.0 300 295.6 24 275 22 250 20 2016 2017 2018 2019 2016 2017 2018 2019 • Revenue flat at $340m • Operating Profit down 5.5% at $27.3m • Operating Profit margin decreased
Slide 8: Future Focus
Future Focus Retail and Health Customer Engagement Network Scale Financial Returns Focus on core retail Optimise digital health and Continue to grow the Reshape to fit new disciplines retail communications franchise network environment Grow exclusive product channels with customers range Optimise eq
Slide 9: Medical Performance
Medical Performance Medical Operating Revenue Medical Operating Profit $m $m 80 5 70.5 4.4 4 3.7 60 52.7 49.3 46.5 2.9 3 2.8 40 2 20 1 0 0 2016 2017 2018 2019 2016 2017 2018* 2019 • Revenue up 33.8% to $70.5m • Operating Profit up 20.4% to $4.4m • Operating Profit margin decreased from 7.0% to 6.3%
Slide 10: Future Focus
Future Focus Network Scale Customer Engagement Financial Returns Network and patient number Deploy digital technology to Continuous improvement in growth through targeted increase efficiency and enhance operational efficiency and scale acquisition and market delivery of high quality patient to creat
Slide 11: Community Health Performance
Community Health Performance Community Health Operating Revenue Community Health Operating Profit $m $m 156.5 4 160 143.2 3.0 115.7 3 120 105.7 80 2 1.2 40 1 0.6 0.1 0 0 2016 2017 2018* 2019 2016 2017 2018* 2019 • Revenue up 9.3% to $156.5m1 • Operating Profit was down $1.1m to $0.1m2 due to continu
Slide 12: Future Focus
Future Focus Service Offering Digital Communication Financial Returns Focus on higher clinical needs Harness technology to enhance Negotiate sustainable funding for segments workforce efficiency and client existing and future contracts outcomes Expand geographic coverage of Exit contracts that are n
Slide 13: Group Financial Result
Group Financial Result 12 months ending 31 March 2019 GXH Annual Shareholders’ Meeting Presentation 30 July 2019 Pg 13
Slide 14: Group Revenue and Profit
Group Revenue and Profit GXH Operating Revenue GXH Operating Profit $m $m 600 567.2 36 34.9 537.2 487.6 500 447.7 400 32 30.1 30.0 300 29.4 200 28 100 0 24 2016 2017 2018* 2019 2016+# 2017+# 2018* 2019 • Revenue of $567m up 5.6% • Operating Profit (EBIT + associate earnings) $29.4m down 2.2% • EBITD
Slide 15: Net Profit After Tax (attributable to shareholders)
Net Profit After Tax (attributable to shareholders) GXH Net Profit after Tax attributable to Shareholders $m 25 19.6 20 17.0 15.6 16.1 15 10 5 0 2016+# 2017+# 2018* 2019 • Net Profit after Tax attributable to shareholders of $16.1m up 3.2% from $15.6m1 Note: * & 1 : 2018 restated to incorporate chan
Slide 16: Operating Cash / Investments
Operating Cash / Investments Operating Cash Flow • Operating Cash of $29.5m $m • Reverted to normal level (after Pay Equity pre- 35 33.1 funding in Community Health in 2018) 29.9 30 29.5 Enabling investment in: • New acquisitions – net $3.4m, including: 25 – St Heliers Health Centre 20 18.4 – Waimau
Slide 17: Net Debt / Debt Capacity
Net Debt / Debt Capacity Net Debt (Borrowings Less Cash) $m • 15% improvement in Net Debt to $32.5m 0 2016 2017 2018 2019 • $18m headroom on core debt facility of $60m and $20m headroom on secondary facility of $30m2 -10 • Financing ratios: -20 – DEBT / EBITDA – 1.33x – EBIT / Interest – 14.3x -30 –
Slide 18: Earnings Per Share / Dividends
Earnings Per Share / Dividends Earnings Per Share 14.18 • EPS marginally up at 11.22 cps 12.53 • Final Dividend consistent @ 3.5 cps 11.02 11.22 • Gross Dividend Yield ~8.5% 2016 2017 2018* 2019 Note: * 2018 restated to incorporate changes in Accounting Standards and restatement of alternate leave l
Slide 19: Resolutions & Voting
Resolutions & Voting GXH Annual Shareholders’ Meeting Presentation 30 July 2019 Pg 19
Slide 20: Resolutions
Resolutions • Resolution 1: Re-election of Dr Tony Edwards • Resolution 2: Remuneration of the Auditors • Special Resolution: Revocation and Adoption of new Constitution GXH Annual Shareholders’ Meeting Presentation 30 July 2019 Pg 20
Slide 21: Q&A
Q&A GXH Annual Shareholders’ Meeting Presentation 30 July 2019 Pg 21
Slide 22: Disclaimer
Disclaimer The information in this presentation was prepared by Green Cross Health Limited (GXH) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliability